Outcomes of Intravenous Recombinant Tissue Plasminogen Activator Therapy According to Gender: A Clinical Registry Study and Systematic Review
暂无分享,去创建一个
J. Olivot | P. Amarenco | I. Klein | M. Mazighi | T. Slaoui | B. Lapergue | G. Raphaeli | J. Labreuche | E. Meseguer | P. Lavallée | L. Cabrejo | C. Guidoux | H. Abboud | C. Arnaiz | Philippa C. Lavallée
[1] Gary A. Ford,et al. Multivariable Analysis of Outcome Predictors and Adjustment of Main Outcome Results to Baseline Data Profile in Randomized Controlled Trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST) , 2008, Stroke.
[2] D. Kent,et al. The gender effect in stroke thrombolysis , 2008, Neurology.
[3] J. De Keyser,et al. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke. , 2008, Archives of neurology.
[4] Á. Chamorro,et al. The response to IV rt‐PA in very old stroke patients , 2008, European journal of neurology.
[5] Determinants of outcome in patients eligible for thrombolysis for ischemic stroke , 2007, Vascular health and risk management.
[6] W. Heiss,et al. The Cologne Stroke Experience: Safety and Outcome in 450 Patients Treated with Intravenous Thrombolysis , 2007, Cerebrovascular Diseases.
[7] G. Albers,et al. Symptomatic Intracerebral Hemorrhage following Thrombolytic Therapy for Acute Ischemic Stroke: A Review of the Risk Factors , 2007, Cerebrovascular Diseases.
[8] W. Koroshetz,et al. Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke , 2007, Neurology.
[9] Zsolt Garami,et al. Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke , 2007, Stroke.
[10] A. Alexandrov,et al. Clinical Deterioration After Intravenous Recombinant Tissue Plasminogen Activator Treatment: A Multicenter Transcranial Doppler Study , 2007, Stroke.
[11] M. A. Moro,et al. Increased Body Iron Stores Are Associated With Poor Outcome After Thrombolytic Treatment in Acute Stroke , 2007, Stroke.
[12] J. Martí-Fàbregas,et al. Frequency and Predictors of Symptomatic Intracerebral Hemorrhage in Patients with Ischemic Stroke Treated with Recombinant Tissue Plasminogen Activator outside Clinical Trials , 2006, Cerebrovascular Diseases.
[13] D. Kent,et al. Sex-Based Differences in the Effect of Intra-Arterial Treatment of Stroke: Analysis of the PROACT-2 Study , 2006, Stroke.
[14] V. Hachinski,et al. Neglecting the Difference: Does Right or Left Matter in Stroke Outcome After Thrombolysis? , 2006, Stroke.
[15] C. Baumann,et al. Early Recurrent Ischemic Stroke in Stroke Patients Undergoing Intravenous Thrombolysis , 2006, Circulation.
[16] M. Schrooten,et al. Body temperature and outcome after stroke thrombolysis , 2006, Acta neurologica Scandinavica.
[17] J. Montaner,et al. Pretreatment Hemostatic Markers of Symptomatic Intracerebral Hemorrhage in Patients Treated With Tissue Plasminogen Activator , 2006, Stroke.
[18] M. Reichhart,et al. Thrombolysis in stroke patients aged 80 years and older: Swiss survey of IV thrombolysis , 2005, Neurology.
[19] J. Röther,et al. Outcome and Severe Hemorrhagic Complications of Intravenous Thrombolysis With Tissue Plasminogen Activator in Very Old (≥80 Years) Stroke Patients , 2005, Stroke.
[20] V. Hachinski,et al. Predictors of major neurologic improvement after thrombolysis in acute stroke , 2005, Neurology.
[21] D. Emery,et al. Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[22] G. Schlaug,et al. Arterial Occlusive Lesions Recanalize More Frequently in Women Than in Men After Intravenous Tissue Plasminogen Activator Administration for Acute Stroke , 2005, Stroke.
[23] P. Sandercock,et al. Influence of Gender on Baseline Features and Clinical Outcomes among 17,370 Patients with Confirmed Ischaemic Stroke in the International Stroke Trial , 2005, Neuroepidemiology.
[24] F. Silver,et al. Sex Differences in Stroke Care and Outcomes: Results From the Registry of the Canadian Stroke Network , 2005, Stroke.
[25] S. Warach,et al. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. , 2005, AJNR. American journal of neuroradiology.
[26] L. Price,et al. Sex-Based Differences in Response to Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Pooled Analysis of Randomized Clinical Trials , 2005, Stroke.
[27] P. Heuschmann,et al. Predictors of in-hospital mortality in patients with acute ischemic stroke treated with thrombolytic therapy. , 2004, JAMA.
[28] V. Hachinski,et al. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. , 2004, JAMA.
[29] B. Norrving,et al. Sex Differences in Management and Outcome After Stroke: A Swedish National Perspective , 2003, Stroke.
[30] A. Carter,et al. Gender differences in coagulation and fibrinolysis in white subjects with acute ischemic stroke , 2003, Journal of thrombosis and haemostasis : JTH.
[31] Andrew M. Demchuk,et al. Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey , 2002, Circulation.
[32] D. Tanné,et al. Predictors of good outcome after intravenous tPA for acute ischemic stroke , 2001, Neurology.
[33] A. Carter,et al. Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular disease , 2001, British journal of haematology.
[34] A. Shah,et al. Baseline Computed Tomography Changes and Clinical Outcome After Thrombolysis With Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke , 2001, Journal of neuroimaging : official journal of the American Society of Neuroimaging.
[35] B. Crain,et al. Estrogen Receptor Antagonist ICI182,780 Exacerbates Ischemic Injury in Female Mouse , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] Robert D. Brown,et al. vator for acute ischemic stroke : feasibility , safety , and efficacy in the first year of clinical practice , 1999 .
[37] Wei Li,et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territory stroke: determination of etiological, topographic, and radiological outcome factors. , 1998, Stroke.
[38] J. Grotta,et al. Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. , 1998, Stroke.
[39] Joseph P. Broderick,et al. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .